Correlation Between Neovacs SA and DBT SA
Can any of the company-specific risk be diversified away by investing in both Neovacs SA and DBT SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neovacs SA and DBT SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neovacs SA and DBT SA, you can compare the effects of market volatilities on Neovacs SA and DBT SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neovacs SA with a short position of DBT SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neovacs SA and DBT SA.
Diversification Opportunities for Neovacs SA and DBT SA
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Neovacs and DBT is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Neovacs SA and DBT SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DBT SA and Neovacs SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neovacs SA are associated (or correlated) with DBT SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DBT SA has no effect on the direction of Neovacs SA i.e., Neovacs SA and DBT SA go up and down completely randomly.
Pair Corralation between Neovacs SA and DBT SA
Assuming the 90 days trading horizon Neovacs SA is expected to generate 3.94 times more return on investment than DBT SA. However, Neovacs SA is 3.94 times more volatile than DBT SA. It trades about 0.0 of its potential returns per unit of risk. DBT SA is currently generating about -0.03 per unit of risk. If you would invest 2,800 in Neovacs SA on August 31, 2024 and sell it today you would lose (2,800) from holding Neovacs SA or give up 100.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 72.31% |
| Values | Daily Returns |
Neovacs SA vs. DBT SA
Performance |
| Timeline |
| Neovacs SA |
| DBT SA |
Neovacs SA and DBT SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neovacs SA and DBT SA
The main advantage of trading using opposite Neovacs SA and DBT SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neovacs SA position performs unexpectedly, DBT SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DBT SA will offset losses from the drop in DBT SA's long position.The idea behind Neovacs SA and DBT SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |